Researchers in Belgium report that histone deacetylase inhibitors might be beneficial in chronic kidney disease. Using a mouse model of glomerulosclerosis, Van Beneden and co-workers showed that administration of valproic acid before kidney injury prevented proteinuria and kidney disease; when administered after proteinuria was established, valproic acid decreased proteinuria and limited progression of renal disease.